Survival – The Year No-One Could Have Expected

On the evening of 18th September 2017, a merciless Maria passed over Dominica as a Category 5 hurricane, striking with winds in excess of 175 miles per hour, reshaped Dominica’s social, physical and economic landscape and threaten the future viability as a nation.

Currently, the Government has presented on July 2018 The National Budget Of The Commonwealth of Dominica Fiscal Year 2018 – 2019, “From Survival, To Sustainability And Success: A Resilient Dominica”.

This important document addressed that the Ministry of Health and Social Service will focus on the seven (7) pillars of World Health Organization (WHO)/Pan American Health Organization (PAHO) which capture the building blocks for health systems strengthening. These are service delivery, health workforce, health information system, access to essential medicine, financing, leadership/governance and community participation.

For more information go to

http://finance.gov.dm/budget/budget-addresses/file/27-budget-address-2018-2019-from-survival-to-sustainability-and-success-a-resilient-dominica

FDA’s Division of Drug Information in the Center for Drug Evaluation and Research (CDER) is excited to present a series of educational webinars targeting the needs of all health care professionals and students, including physicians, physician assistants, nurses, pharmacists, and pharmacy technicians. Interact with FDA staff from a variety of divisions and learn more about the FDA and drug regulation!

On Tuesday, September 18, 2018, at 1:00PM (EDT), CDER’s Office of Communication, Division of Drug Information (DDI) will host a webinar titled: FDA Drug Topics: Building Confidence in Generic Narrow Therapeutic Index (NTI) Drugs. This webinar will introduce the general characteristics of Narrow Therapeutic Index or NTI drugs and discuss FDA’s innovative approach and criteria for generic NTI drug equivalence evaluation. In addition, we will discuss results from a bioequivalence study comparing brand and generic tacrolimus (an NTI drug) capsules in stable transplant patients to address patients’ and health practitioners’ questions regarding substitutability of generic immunosuppressant drugs.

For more information go to https://www.fda.gov/AboutFDA/WorkingatFDA/FellowshipInternshipGraduateFacultyPrograms/PharmacyStudentExperientialProgramCDER/ucm617474.htm

El Ministerio de Salud de Uruguay publica modificación del Formulario Terapéutico de Medicamentos (FTM) que agrega tratamiento de retinitis por citamegalovirus en pacientes con infección por VIH al plan de cobertura del fármaco VALGANCICLOVIR e incorpora el tratamiento de pacientes con infección por el virus de la Hepatitis C por la asociación de los fármacos SOFOSBUVIR+VELPATASVIR.

Fuente:

http://www.msp.gub.uy/sites/default/files/archivos_adjuntos/3-6989-2018.pdf